Wexford Capital Lp
Source: SEC Form 13F · as of Mar 2026Wexford Capital Lp holds 8 biotech & pharma companies tracked by BioSniper, totaling $6.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$6.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ARGENX SE (ARGX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARGXARGENX SE | 1,500 | $1.1M |
| TRVITrevi Therapeutics, Inc. | 90,752 | $1.1M |
| SPRYARS Pharmaceuticals, Inc. | 130,313 | $1.0M |
| STIMNeuronetics Inc. | 700,961 | $1.0M |
| TSHATaysha Gene Therapies, Inc. | 160,654 | $718K |
| GPCRStructure Therapeutics Inc. | 13,709 | $661K |
| NUVBNuvation Bio Inc. | 120,889 | $519K |
| BIOABioAge Labs, Inc. | 25,765 | $451K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.